Symtaz P 250 mg/31.25 mg Injection
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Primary uses of : Bacterial infections
-
-
-
*
-
|
Composition
|
Ceftriaxone (250mg) + Tazobactum (31.25mg) |
|
Side Effect
|
Common
Diarrhoea, Increased liver enzymes, Allergic reaction, Rash. |
|
How to works
|
How Symtaz P Injection works
Symtaz P 250 mg/31.25 mg Injection is a combination of two medicines: Ceftriaxone and Tazobactum. Ceftriaxone is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria in the human body. Tazobactum is a beta-lactamase inhibitor which reduces resistance and enhances the activity of Ceftriaxone against bacteria. |
